Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Joint Bone Spine
|
May 25, 2025
Advanced combination therapy in inflammatory bowel disease
Caroline Morizot, Léa Sequier, Jean-Yves Jouzeau, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 24, 2022
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study
Raphael P Luber, Alexa Duff, Polychronis Pavlidis, et al.
Journal of Crohn'S & Colitis
|
December 28, 2021
Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment
Sailish Honap, Susanna Meade, Ashley Spencer, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
December 11, 2025
Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary center
Michael Colwill, Jessica Padley, Umang Qazi, et al.
Frontline Gastroenterology
|
July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?
Susanna Meade, Emma Routledge, Esha Sharma, et al.
Frontline Gastroenterology
|
October 17, 2022
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
Sailish Honap, Lulia Al-Hillawi, Samantha Baillie, et al.
Frontline Gastroenterology
|
May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response
Mark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 8, 2025
Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review With Meta-analysis
Sudheer K Vuyyuru, Nader Shaban, Yuhong Yuan, et al.
Alimentary Pharmacology & Therapeutics
|
July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch
Raphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.
Journal of Crohn'S & Colitis
|
April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
Sailish Honap, Desmond Chee, Thomas P Chapman, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Joint Bone Spine
|
May 25, 2025
Advanced combination therapy in inflammatory bowel disease
Caroline Morizot, Léa Sequier, Jean-Yves Jouzeau, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 24, 2022
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study
Raphael P Luber, Alexa Duff, Polychronis Pavlidis, et al.
Journal of Crohn'S & Colitis
|
December 28, 2021
Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment
Sailish Honap, Susanna Meade, Ashley Spencer, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
December 11, 2025
Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary center
Michael Colwill, Jessica Padley, Umang Qazi, et al.
Frontline Gastroenterology
|
July 6, 2023
How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?
Susanna Meade, Emma Routledge, Esha Sharma, et al.
Frontline Gastroenterology
|
October 17, 2022
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
Sailish Honap, Lulia Al-Hillawi, Samantha Baillie, et al.
Frontline Gastroenterology
|
May 19, 2020
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response
Mark A Samaan, Siddharth Birdi, Maria Sierra Morales, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 8, 2025
Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review With Meta-analysis
Sudheer K Vuyyuru, Nader Shaban, Yuhong Yuan, et al.
Alimentary Pharmacology & Therapeutics
|
July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch
Raphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.
Journal of Crohn'S & Colitis
|
April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
Sailish Honap, Desmond Chee, Thomas P Chapman, et al.
Page
of 6